GlobeNewswire Inc | Nov 16, 2020 08:00AM EST

November 16, 2020

ATLANTA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that Rick Eiswirth, Alimeras President and Chief Executive Officer, will participate in the Craig-Hallum Capital Groups annual Alpha Select Conference on Tuesday November 17, 2020. The conference consists of one-on-one and small group meetings, which will take place via video conference.

Attendees of the conference can schedule a meeting with Mr. Eiswirth here.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries:Jules Abraham For investor inquiries:for Alimera Sciences Scott Gordon917-885-7378 for Alimera Sciencesjulesa@coreir.com scottg@coreir.com